News Release

Japan’s first nationwide survey highlights gaps in patient engagement for allergy research

Findings reveal strong patient advocacy but limited researcher involvement, underscoring policy priorities for patient-centered care

Peer-Reviewed Publication

Keio University

PPIE Graphical Abstract

image: 

This study examined patient and public involvement and engagement (PPIE) in allergy research in Japan through a comparative survey of patient advocacy groups (PAGs) and principal investigators (PIs). 
Allergy PAGs showed higher engagement and stronger recognition of PPIE necessity compared to other disease areas, while researchers demonstrated limited awareness and formal rules. 
Key unmet needs included training programs, coordinators to facilitate collaboration, and practical toolkits. 
The findings highlight gaps between PAGs and researchers and provide insights to guide national and global efforts for advancing patient-centered allergy research and for sustainable and effective PPIE.
view more 

Credit: © 2025 Utako Okata-Karigane and Takeya Adachi et al., Keio University School of Medicine. Used with permission.

Tokyo, Japan – [Sept 18, 2025] –
A team of researchers from Keio University School of Medicine, the Institute of Medical Science at the University of Tokyo, and the National Center for Child Health and Development has reported the first cross-disease, cross-stakeholder survey on PPIE in Japan. The study compared allergy research with cancer and rare diseases, fields where PPIE has already advanced.  

 

The survey revealed that:
•100% of allergy-related PAGs considered PPIE essential, and 50% had formal rules for engagement.

•By contrast, only 9.4% of allergy researchers reported established rules, and just 50% recognized PPIE as necessary—lower than in cancer and rare disease research (64.7%).

•PAGs identified three priorities: (1) training programs for both patients and researchers, (2) coordinators to support collaboration, and (3) toolkits and case studies to guide implementation.

•PAGs widely used digital tools for communication (100%), while adoption among researchers was minimal (6.3–15.6%).  

 

“These findings show that allergy patient advocacy groups in Japan are ready and willing to engage, but researchers have yet to catch up,” said Dr. Takeya ADACHI, corresponding author and dermatologist at Keio University. “Closing this gap is critical, especially since allergy management depends heavily on daily-life factors such as environment and lifestyle. Patient perspectives are essential to shaping meaningful research.”  

 

The study also emphasized that these results align with the Japan Agency for Medical Research and Development (AMED) initiatives to promote PPIE as part of national health policy. Their presentation at the UNGA Science Summit 2025 further highlights the global significance of advancing inclusive, patient-centered research practices.

 

About the Study: The study, titled “Exploring Patient and Public Involvement and Engagement in Allergy Research: Cross-Disease and Cross-Stakeholder Perspectives in Japan”, was published in Allergy on September 18, 2025. 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.